ImPulse Growth AD（IMP）株式概要インパルス・グロースADは、ブルガリアの配当企業や様々な金融商品に投資している。 詳細IMP ファンダメンタル分析スノーフレーク・スコア評価4/6将来の成長0/6過去の実績3/6財務の健全性6/6配当金0/6報酬当社が推定した公正価値より47.7%で取引されている 過去1年間で収益は26.9%増加しました リスク分析意味のある時価総額がありません ( €5M )BG市場と比較した過去 3 か月間の株価の変動意味のある収益がありません ( BGN2M )過去1年間で株主の希薄化が進んだ すべてのリスクチェックを見るIMP Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.6558.5% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-399k2m2016201920222025202620282031Revenue лв1.7mEarnings лв1.5mAdvancedSet Fair ValueView all narrativesImPulse Growth AD 競合他社Real Bulland ADSymbol: BUL:RBLMarket cap: €7.6mBulgarian Private Equity Fund ADSymbol: BUL:BPEFMarket cap: €23.7mChernomorski Holding ADSymbol: BUL:CHLMarket cap: €24.0mEleven Capital ADSymbol: BUL:11CMarket cap: €17.9m価格と性能株価の高値、安値、推移の概要ImPulse Growth AD過去の株価現在の株価€0.6552週高値€0.8152週安値€0.36ベータ0.141ヶ月の変化1.56%3ヶ月変化0%1年変化-15.38%3年間の変化16.62%5年間の変化n/aIPOからの変化-2.19%最新ニュースNew Risk • May 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bulgarian stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€4.52m market cap, or US$5.25m). Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding). Revenue is less than US$5m (лв1.7m revenue, or US$1.0m).New Risk • Mar 26Current risksCurrently, the following risks have been identified for the company: Major Risks: Share price has been highly volatile over the past 3 months (37% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m. Minor Risks: Shareholders have been diluted in the past year (17% increase in shares outstanding).Buy Or Sell Opportunity • Feb 02Now 21% undervaluedOver the last 90 days, the stock has risen 9.7% to €0.79. The fair value is estimated to be €0.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last 3 years. Meanwhile, the company has become profitable.New Risk • Jan 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bulgarian stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Revenue is less than US$1m (лв1.2m revenue, or US$697k). Market cap is less than US$10m (лв10.0m market cap, or US$6.03m). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding).Buy Or Sell Opportunity • Sep 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.5% to лв1.50. The fair value is estimated to be лв1.89, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last 3 years. Meanwhile, the company has become profitable.New Risk • Sep 16New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (лв1.2m revenue, or US$701k). Market cap is less than US$10m (лв10.7m market cap, or US$6.44m). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding).最新情報をもっと見るRecent updatesNew Risk • May 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bulgarian stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€4.52m market cap, or US$5.25m). Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding). Revenue is less than US$5m (лв1.7m revenue, or US$1.0m).New Risk • Mar 26Current risksCurrently, the following risks have been identified for the company: Major Risks: Share price has been highly volatile over the past 3 months (37% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m. Minor Risks: Shareholders have been diluted in the past year (17% increase in shares outstanding).Buy Or Sell Opportunity • Feb 02Now 21% undervaluedOver the last 90 days, the stock has risen 9.7% to €0.79. The fair value is estimated to be €0.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last 3 years. Meanwhile, the company has become profitable.New Risk • Jan 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bulgarian stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Revenue is less than US$1m (лв1.2m revenue, or US$697k). Market cap is less than US$10m (лв10.0m market cap, or US$6.03m). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding).Buy Or Sell Opportunity • Sep 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.5% to лв1.50. The fair value is estimated to be лв1.89, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last 3 years. Meanwhile, the company has become profitable.New Risk • Sep 16New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (лв1.2m revenue, or US$701k). Market cap is less than US$10m (лв10.7m market cap, or US$6.44m). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding).Buy Or Sell Opportunity • Aug 21Now 21% undervaluedOver the last 90 days, the stock has risen 1.3% to лв1.52. The fair value is estimated to be лв1.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only.Buy Or Sell Opportunity • Aug 06Now 22% undervaluedThe stock has been flat over the last 90 days, currently trading at лв1.50. The fair value is estimated to be лв1.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only.お知らせ • May 16ImPulse Growth AD, Annual General Meeting, Jun 16, 2025ImPulse Growth AD, Annual General Meeting, Jun 16, 2025, at 10:00 FLE Standard Time. Location: sofia at 5 lachezar stanchev, sopharma business towers ground floor, sopharma event center, BulgariaBuy Or Sell Opportunity • Mar 21Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 3.3% to лв1.45. The fair value is estimated to be лв1.84, however this is not to be taken as a buy recommendation but rather should be used as a guide only.New Risk • Mar 16New major risk - Revenue and earnings growthRevenue has declined by 21% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 21% over the past year. Revenue is less than US$1m (лв1.3m revenue, or US$733k). Market cap is less than US$10m (лв8.59m market cap, or US$4.78m).New Risk • Mar 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (лв757k revenue, or US$421k). Market cap is less than US$10m (лв8.23m market cap, or US$4.58m). Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).株主還元IMPBG Capital MarketsBG 市場7D-1.5%-0.6%1.3%1Y-15.4%11.2%15.6%株主還元を見る業界別リターン: IMP過去 1 年間で11.2 % の収益を上げたBG Capital Markets業界を下回りました。リターン対市場: IMPは、過去 1 年間で15.6 % のリターンを上げたBG市場を下回りました。価格変動Is IMP's price volatile compared to industry and market?IMP volatilityIMP Average Weekly Movement7.5%Capital Markets Industry Average Movement4.3%Market Average Movement4.8%10% most volatile stocks in BG Market7.6%10% least volatile stocks in BG Market3.1%安定した株価: IMPの株価は、 BG市場と比較して過去 3 か月間で変動しています。時間の経過による変動: IMPの 週次ボラティリティ は過去 1 年間で18%から8%に減少しましたが、依然としてBG株の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2021n/an/awww.impulsegrowth.euインパルス・グロースADはブルガリアの配当企業や様々な金融商品に投資している。インパルス・グロースADの前身はインパルスI ADで、2022年12月にインパルス・グロースADに社名変更した。同社は2021年に設立され、ブルガリアのソフィアを拠点としている。もっと見るImPulse Growth AD 基礎のまとめImPulse Growth AD の収益と売上を時価総額と比較するとどうか。IMP 基礎統計学時価総額€4.59m収益（TTM）€760.97k売上高(TTM)€880.82k6.0xPER（株価収益率5.2xP/SレシオIMP は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計IMP 損益計算書（TTM）収益лв1.68m売上原価лв0売上総利益лв1.68mその他の費用лв229.00k収益лв1.45m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）0.21グロス・マージン100.00%純利益率86.39%有利子負債／自己資本比率0%IMP の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/22 20:46終値2026/06/18 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋ImPulse Growth AD 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • May 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bulgarian stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€4.52m market cap, or US$5.25m). Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding). Revenue is less than US$5m (лв1.7m revenue, or US$1.0m).
New Risk • Mar 26Current risksCurrently, the following risks have been identified for the company: Major Risks: Share price has been highly volatile over the past 3 months (37% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m. Minor Risks: Shareholders have been diluted in the past year (17% increase in shares outstanding).
Buy Or Sell Opportunity • Feb 02Now 21% undervaluedOver the last 90 days, the stock has risen 9.7% to €0.79. The fair value is estimated to be €0.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last 3 years. Meanwhile, the company has become profitable.
New Risk • Jan 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bulgarian stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Revenue is less than US$1m (лв1.2m revenue, or US$697k). Market cap is less than US$10m (лв10.0m market cap, or US$6.03m). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding).
Buy Or Sell Opportunity • Sep 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.5% to лв1.50. The fair value is estimated to be лв1.89, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last 3 years. Meanwhile, the company has become profitable.
New Risk • Sep 16New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (лв1.2m revenue, or US$701k). Market cap is less than US$10m (лв10.7m market cap, or US$6.44m). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding).
New Risk • May 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bulgarian stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€4.52m market cap, or US$5.25m). Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding). Revenue is less than US$5m (лв1.7m revenue, or US$1.0m).
New Risk • Mar 26Current risksCurrently, the following risks have been identified for the company: Major Risks: Share price has been highly volatile over the past 3 months (37% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m. Minor Risks: Shareholders have been diluted in the past year (17% increase in shares outstanding).
Buy Or Sell Opportunity • Feb 02Now 21% undervaluedOver the last 90 days, the stock has risen 9.7% to €0.79. The fair value is estimated to be €0.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last 3 years. Meanwhile, the company has become profitable.
New Risk • Jan 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bulgarian stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Revenue is less than US$1m (лв1.2m revenue, or US$697k). Market cap is less than US$10m (лв10.0m market cap, or US$6.03m). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding).
Buy Or Sell Opportunity • Sep 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.5% to лв1.50. The fair value is estimated to be лв1.89, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last 3 years. Meanwhile, the company has become profitable.
New Risk • Sep 16New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (лв1.2m revenue, or US$701k). Market cap is less than US$10m (лв10.7m market cap, or US$6.44m). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding).
Buy Or Sell Opportunity • Aug 21Now 21% undervaluedOver the last 90 days, the stock has risen 1.3% to лв1.52. The fair value is estimated to be лв1.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
Buy Or Sell Opportunity • Aug 06Now 22% undervaluedThe stock has been flat over the last 90 days, currently trading at лв1.50. The fair value is estimated to be лв1.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
お知らせ • May 16ImPulse Growth AD, Annual General Meeting, Jun 16, 2025ImPulse Growth AD, Annual General Meeting, Jun 16, 2025, at 10:00 FLE Standard Time. Location: sofia at 5 lachezar stanchev, sopharma business towers ground floor, sopharma event center, Bulgaria
Buy Or Sell Opportunity • Mar 21Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 3.3% to лв1.45. The fair value is estimated to be лв1.84, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
New Risk • Mar 16New major risk - Revenue and earnings growthRevenue has declined by 21% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 21% over the past year. Revenue is less than US$1m (лв1.3m revenue, or US$733k). Market cap is less than US$10m (лв8.59m market cap, or US$4.78m).
New Risk • Mar 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (лв757k revenue, or US$421k). Market cap is less than US$10m (лв8.23m market cap, or US$4.58m). Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).
